Racial and ethnic disparities in disease-modifying therapy use among adults with multiple sclerosis: a real-world analysis of the All of Us Research Program

Victoria Fontánez-Ramos, Jonathan Barreto-Nieves, Grecia A. Carrasquillo-Sanabria, Jorge F. García-Báez, Yaritza Inostroza-Nieves · 2026

Read Racial and ethnic disparities in disease-modifying therapy use among adults with multiple sclerosis: a real-world analysis of the All of Us Research Program by Victoria Fontánez-Ramos, Jonathan Barreto-Nieves, Grecia A. Carrasquillo-Sanabria, Jorge F. García-Báez, Yaritza Inostroza-Nieves (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13616653.txt.

Description

Fontánez-Ramos and co-authors present a 2026 analysis of racial and ethnic gaps in multiple sclerosis drug use. Disease-modifying therapies slow the disease, but access along the care path is uneven. The team used the All of Us research program, a large national data set. Their cohort held 3,508 adults with confirmed disease.

Under half of patients ever started a therapy. Hispanic patients had the lowest start rate, while Black patients started most often but waited longest for a first drug. Use of high-strength drugs varied widely across race and sex groups. Most starters stopped within six months by the study's measure. The authors map gaps at each step of treatment.

Catalog record

CREATORVictoria Fontánez-Ramos, Jonathan Barreto-Nieves, Grecia A. Carrasquillo-Sanabria, Jorge F. García-Báez, Yaritza Inostroza-Nieves
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13616653

Browse the full library · About the Tower of Babel